PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Emmaus Life Sciences, Inc.
Filed: April 26, 2013
Period of Report: April 26, 2013
Accession Number: 0001144204-13-024353

View Document ↗ View on SEC.gov ↗